Showing results (1661-1670 of 3,526) with videos related to
Sort By:
Pageof 353
Thoracic Cancer|September 8, 2023
miR-1301-3p promotes invasion and migration and EMT progression in esophageal cancer by downregulating NBL1 expressionJianting Du, Shuliang Zhang, Xiaodan Zhang, et al.Thoracic Cancer|August 24, 2023
A rare case of double primary lung adenocarcinomas with uncommon complex EGFR G719X and S768I mutations and pleomorphic carcinomaToshiki Morimoto, Kei Yamasaki, Tatsuya Shingu, et al.Thoracic Cancer|August 24, 2023
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non-small cell lung cancer from proteomic profiling of circulating extracellular vesiclesMasahiro Torasawa, Hidehito Horinouchi, Shigehiro Yagishita, et al.Thoracic Cancer|August 22, 2023
Clinicopathological impact of VEGFR2 and VEGF-C in patients with EGFR-major mutant NSCLC receiving osimertinibKyoichi Kaira, Hisao Imai, Atsuto Mouri, et al.Thoracic Cancer|August 17, 2023
Phase II trial of daily S-1 combined with weekly irinotecan in previously treated patients with advanced or recurrent squamous cell lung cancer: North Japan lung cancer group 1101Yosuke Kawashima, Osamu Ishimoto, Eisaku Miyauchi, et al.Thoracic Cancer|August 19, 2023
Preliminary investigation of elevated collagen and blood-clotting markers as potential noninvasive biomarkers for small cell lung cancerJeppe Thorlacius-Ussing, Søren Risom Kristensen, Morten Asser Karsdal, et al.Thoracic Cancer|August 18, 2023
Role of prognostic nutritional index in postoperative radiotherapy for non-small cell lung cancerHyejo Ryu, Changhoon Song, Jae-Sung Kim, et al.Thoracic Cancer|August 19, 2023
Investigation of the efficacy and feasibility of combined therapy of PD-L1-enhanced exogenous peripatetic adoptive natural killer (NK) cells in combination with antiangiogenic targeted therapy in the treatment of extensive-stage small cell lung cancerZhizhen Wang, Ruiping Zhang, Yuchan Cao, et al.Thoracic Cancer|August 19, 2023
Enhanced prediction of postoperative radiotherapy-induced esophagitis in non-small cell lung cancer: Dosiomic model development in a real-world cohort and validation in the PORT-C randomized controlled trialZeliang Ma, Bin Liang, Ran Wei, et al.Thoracic Cancer|August 16, 2023
Breviscapine reverses doxorubicin resistance in breast cancer and its related mechanismsWeijiang Fu, Jie Song, Haiying LiPageof 353